» Articles » PMID: 10674973

Polymorphic Analysis of the High-affinity Tumor Necrosis Factor Receptor 2

Overview
Journal Tissue Antigens
Date 2000 Feb 16
PMID 10674973
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor necrosis factor receptor 2 (TNF-RII, CD120b, TNF-R p75/80) gene has recently been characterised. It is located on chromosome 1p362 and consists of 10 exons and 9 introns A number of biallelic polymorphisms have been found in exons 4, 6, 9 and 10 based on differences between published sequences. In this study we have used polymerase chain reaction methodology in association with sequence-specific primers (PCR-SSP) incorporating mismatches at the 3' end to identify these polymorphisms. We were able to confirm the presence of a single biallelic polymorphism in exon 6 corresponding to a (T/G) at nucleotide 676 of TNF-RII mRNA (gb:M32315) which results in an amino acid change and three biallelic polymorphisms in exon 10 (in the3'UTR) corresponding to (A/G) at nucleotide 1663, (T/G) at nucleotide 1668 and a (C/T) at nucleotide 1690 of gb:M32315, whereas no polymorphisms were observed in exons 4 and 9. Here we report that in 192 unrelated UK Caucasian individuals the allele frequencies determined by direct counting were: 676-T (0.77), 1663-G (0.51), 1668-T (0.95), and 1690-T (0.64) and the calculated gene frequencies were; 676-T (0.52), 676-G (0.12); 1663-G (0.30), 1663-A (0.28); 1668-T (0.77), 1668-G (0.025); and 1690-T (0.40), 1690-C (0.20). Furthermore, the presence of an A allele at nucleotide position 1663 was found to be strongly associated with the presence of a C allele at nucleotide position 1690 and a G allele at nucleotide position 1668 whereas the presence of a G allele at position 1663 was associated with the absence of a C allele at nucleotide position 1690.

Citing Articles

Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma.

Carvalho B, Gomez G, Carron J, Macedo L, Goncalves G, de Lima Vazquez V Int J Mol Sci. 2024; 25(5).

PMID: 38474115 PMC: 10932403. DOI: 10.3390/ijms25052868.


Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Menegatti S, Bianchi E, Rogge L Front Immunol. 2019; 10:382.

PMID: 30941119 PMC: 6434926. DOI: 10.3389/fimmu.2019.00382.


Reduced Recovery of Depression in Female T Allele Carriers of rs1061622 at Earlier Stage after Wenchuan Earthquake.

Memon N, Fan M, Lin J, Si Y, Su M, Guo Q Int J Environ Res Public Health. 2018; 15(6).

PMID: 29799484 PMC: 6025417. DOI: 10.3390/ijerph15061075.


Remifentanil preconditioning alleviating brain damage of cerebral ischemia reperfusion rats by regulating the JNK signal pathway and TNF-α/TNFR1 signal pathway.

Zhang Y, Li Y, Wang Y, Zhang H, Zhang X, Liang Y Mol Biol Rep. 2013; 40(12):6997-7006.

PMID: 24190484 DOI: 10.1007/s11033-013-2819-5.


Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFalpha therapy in rheumatoid arthritis?.

Ongaro A, De Mattei M, Pellati A, Caruso A, Ferretti S, Masieri F Rheumatol Int. 2008; 28(9):901-8.

PMID: 18309487 DOI: 10.1007/s00296-008-0552-5.